{
  "context": {
    "rules": [
      "Rule1: Provided that drug_x contains an active ingredient, it will be released to the market.",
      "Rule2: If a purified compound is obtained for drug_x, then it contains an active ingredient.",
      "Rule3: Whenever manufacturing is halted for drug_x, it is due to contamination being detected.",
      "Rule4: Assuming packaging material is material_p, it is sensitive to moisture.",
      "Rule5: When packaging material is material_p, it is not the case that sterile packaging is provided.",
      "Rule6: In the case that packaging material is material_p, light protection is not included.",
      "Rule7: Either a visual inspection is done on material_p or there is no packaging defect.",
      "Rule8: An automated check is performed on material_p, or visual inspection does not occur.",
      "Rule9: If vehicle_v is used for transport, then it is temperature-controlled.",
      "Rule10: Whenever refrigeration failure occurs in vehicle_v, temperature control is not maintained.",
      "Rule11: Either refrigeration failure happens in vehicle_v or backup cooling is available.",
      "Rule12: Assuming an emergency protocol is in place for vehicle_v, temperature control is not ensured.",
      "Rule13: If a quality audit is conducted for drug_x, then if backup cooling is available for vehicle_v, an emergency protocol is in place.",
      "Rule14: Whenever an internal review is done for drug_x, a quality audit is carried out.",
      "Rule15: Either animal testing is performed using animal_m or market release occurs for drug_x.",
      "Rule16: Provided that in vitro testing is conducted on drug_x, animal testing does not happen using animal_m.",
      "Rule17: In vitro testing is done on drug_x, or computer modeling is applied.",
      "Rule18: If computer modeling is applied to drug_x, then simulation is completed.",
      "Rule19: Provided a manufacturing process is in place for drug_x, batch testing is performed.",
      "Rule20: Either a manufacturing process is established for drug_x or quality control is implemented.",
      "Rule21: In the event that results are analyzed for drug_x, animal testing does not happen with animal_m.",
      "Rule22: Whenever a protocol deviation happens for drug_x, if a retest is required, a test failure occurs.",
      "Rule23: A protocol deviation occurs for drug_x, or a standard procedure is followed.",
      "Rule24: Provided a standard procedure is followed for drug_x, then if a retest is required, a test failure happens.",
      "Rule25: In the case that a moisture barrier is provided for material_p, it is not sensitive to moisture.",
      "Rule26: Either packaging approval is granted for material_p, or if packaging material is material_p, a moisture barrier is included.",
      "Rule27: Whenever packaging validation is conducted on material_p, a pressure test is performed.",
      "Rule28: Should seal integrity be ensured for material_p, then if packaging material is material_p, sterile packaging is provided.",
      "Rule29: If quality control is implemented for drug_x, then if regulatory approval is obtained, the lack of market release means compound purity standards are not met.",
      "Rule30: Given that a pressure test is conducted on material_p, seal integrity is ensured.",
      "Rule31: In the event that the supplier is approved for material_p, material_p is certified.",
      "Rule32: Provided an alternate supplier is available for material_p, it is not used as packaging material.",
      "Rule33: A supply chain check is performed for material_p, or direct procurement is used.",
      "Rule34: Whenever direct procurement is used for material_p, either the supplier is approved or an alternate supplier is available.",
      "Rule35: Should quality assurance be applied to material_p, then if a supply chain check is done, either the supplier is approved or an alternate supplier is available.",
      "Rule36: Provided regulatory compliance is maintained for material_p, then if a supply chain check is performed, either the supplier is approved or an alternate supplier is available.",
      "Rule37: In the case that batch testing is performed on drug_x, efficacy testing is conducted.",
      "Rule38: If a contingency plan exists for material_p, then if it is not the case that the absence of quality assurance or regulatory compliance leads to no quarantine, supply is not suspended.",
      "Rule39: Provided a light barrier is used for material_p, light protection is incorporated.",
      "Rule40: Either accelerated aging is conducted on material_p or real-time stability is monitored.",
      "Rule41: If real-time stability is monitored for material_p, then if packaging material is material_p, a light barrier is used.",
      "Rule42: Provided stability is verified for material_p, packaging stability is ensured.",
      "Rule43: In the event that shelf life is determined for material_p, then if accelerated aging is conducted, stability is verified.",
      "Rule44: If safety verification is completed for drug_x, then if regulatory approval is obtained, the lack of market release means compound purity standards are not met.",
      "Rule45: Provided efficacy testing is conducted on drug_x, safety verification is completed.",
      "Rule46: If plant extraction is carried out using plant_a, market release occurs for drug_x.",
      "Rule47: Either plant extraction is done with plant_a or chemical synthesis is used for drug_x.",
      "Rule48: If it is not the case that packaging material being material_p implies sterile packaging, then a packaging defect is found.",
      "Rule49: Provided that the implication from simulation completion to results analysis does not hold, a retest is required.",
      "Rule50: If it is not the case that either quality assurance is applied or regulatory compliance is maintained, material_p is quarantined.",
      "Rule51: If it is not the case that chemical synthesis leads to purified compound, manufacturing is halted.",
      "Rule52: In the event that the negation of the absence of quality assurance or regulatory compliance implying no quarantine does not hold, supply is suspended.",
      "Rule53: If market release does not occur for drug_x, compound purity standards are met.",
      "Rule54: Whenever market release does not happen for drug_x, packaging material is material_p.",
      "Rule55: In the case that market release is absent for drug_x, vehicle_v is used for transport."
    ],
    "facts": [
      "Fact1: Regulatory approval has been obtained for drug_x.",
      "Fact2: An internal review is conducted for drug_x.",
      "Fact3: Packaging validation is performed on material_p.",
      "Fact4: A contingency plan exists for material_p.",
      "Fact5: Shelf life is determined for material_p.",
      "Fact6: It is not the case that contamination is detected in drug_x.",
      "Fact7: An automated check is not performed on material_p.",
      "Fact8: A test failure does not occur for drug_x.",
      "Fact9: Packaging approval is not granted for material_p.",
      "Fact10: Material_p is not certified.",
      "Fact11: Packaging stability is not verified for material_p."
    ]
  },
  "question": "Market release occurs for drug_x."
}